
The FDA just approved a drug that targets cancers based on DNA, rather than where the tumor is in your body
The FDA just approved a new cancer treatment in an unconventional way: not by tumor type, but rather by the genetic mutation the drug targets. The drug, Vitrakvi, was developed by Loxo Oncology in partnership with pharma giant Bayer. It’s only the second time the FDA has approved a cancer drug’s use based on a […]